Loading stock data…
ISRG
$457.78+0.17 (+0.04%)
Market ClosedLast close May 1
Intuitive Surgical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Intuitive Surgical, Inc. in the Healthcare sector is trading at $457.78. The stock is currently near its 52-week low of $427.84, remaining 8.5% below its 200-day moving average. Technical signals show neutral RSI of 50 and bearish MACD signal, explaining why ISRG maintains its current current market pressure. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 50) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$457.78
Potential Downside
64.5%
Whystock Fair Value$162.62
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus30 analysts
Buy
Mean target$577.01+26.0%
Range$378.00 – $750.00
Fundamentals
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Sur...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$171.77B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
58.91
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.68
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
14.63%
Volume
Today's trading volume
1.46M
Recent News
Intuitive Surgical Shareholders Approve All Proposals at 2026 Annual Meeting, Elect 10 Directors
Intuitive Surgical (NASDAQ:ISRG) stockholders voted to approve all four proposals presented at the company’s 2026 Annual Meeting of Stockholders, which was held virtually, according to meeting remarks led by Gary Loeb, executive vice president and chief legal and compliance officer. Annual meeting
Is ISRG's International Weakness a Temporary Drag or Structural Risk?
Intuitive Surgical faces mixed international trends as China pressure and Japan delays cloud otherwise strong OUS growth outlook.
5 Revealing Analyst Questions From Intuitive Surgical’s Q1 Earnings Call
Intuitive Surgical’s first quarter results for 2026 exceeded Wall Street’s expectations, with management crediting the outcome to strong global procedure growth and expansion of the da Vinci and Ion platforms. CEO David Rosa pointed to a 17% increase in total procedures, including “broad-based adoption across da Vinci and Ion as customers continue to advance minimally invasive care.” The company also highlighted notable gains in after-hours and non-urology procedures, as well as expanding uptake
How Strong Q1 2026 Results and Completed Buyback Will Impact Intuitive Surgical (ISRG) Investors
Intuitive Surgical recently reported past first-quarter 2026 results showing revenue of US$2,770.8 million and net income of US$821.5 million, alongside completing a multi-year buyback of 29,440,210 shares for US$9.08 billion. The combination of higher earnings per share and a reduced share count from the long-running repurchase program highlights management’s focus on reinforcing shareholder value through both operating performance and capital allocation. We’ll now examine how this stronger...
Why Intuitive Surgical Is a Strong Buy as Robotic Surgery Adoption Accelerates
Robotic surgery’s market leader has had a rough start to 2026, but our model sees the pullback as an opportunity. Intuitive Surgical (NASDAQ:ISRG) trades at $482.22 after a 14.86% year-to-date decline, even as Q1 procedure growth and da Vinci 5 adoption continue to accelerate. Our 24/7 Wall St. price target for Intuitive Surgical is $615.93, ... Why Intuitive Surgical Is a Strong Buy as Robotic Surgery Adoption Accelerates